Fact CheckerSign in

NCT05459636Completed

Inspiratory Muscle Strength Training in Adults With Obesity

Time-Efficient Inspiratory Muscle Strength Training as a New Approach to Lower Blood Pressure, Improve Respiratory Function, and Reduce Exertional Dyspnea in Adults With Obesity

Source: ClinicalTrials.gov · Last updated 7 Oct 2026

Brief summary (registry, in English)

The purpose of this study is to determine whether inspiratory muscle strength training reduces blood pressure in adults with obesity.

Status (registry)
Completed
Study type
Interventional
Enrollment
44 (actual)
First submitted
13 Jul 2022
Start date
7 Dec 2023
Primary completion date
16 Sept 2026
Lead sponsor
Florida State University
Diseases
Obesity
NCT number
NCT05459636

What you commit to

  • Study type: Interventional
  • Participants enrolled: 44
  • From 7 Dec 2023 to the primary completion date, 16 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous bariatric surgery

Other illness

  • Overt cardiovascular, neurological, renal, liver, and/or metabolic illness (e.g., diabetes mellitus)
  • Current, or history of uncontrolled, Stage 2 hypertension (blood pressure \>140 / 90 mmHg; anti-hypertensive medications are permitted)
  • Diagnosis or signs (e.g., values below the lower limit of normal) of overt airway disease(s)
  • Per the POWERbreathe® company:
    • Patients who have undergone recent abdominal surgery and those with abdominal hernia.
    • Asthma patients who have a very low symptom perception and suffer from frequent, severe exacerbations or with an abnormally low perception of dyspnea.
    • If a patient is suffering from a ruptured eardrum or any other condition of the ear.
    • Patients with marked elevated left ventricular end-diastolic volume and pressure.
    • Patients with worsening heart failure signs and symptoms after training.
    • If an individual is suffering from a cold, sinusitis or respiratory tract infection, it is advised that they do not use the POWERbreathe device.

Other

  • Not weight stable (\<5% change in body mass over the past six months)
  • Diagnosed obstructive sleep apnea
  • Current or recent (regular use within the past 6 months) use of tobacco or nicotine products (e.g., cigarettes, vaping)
  • Pregnant (self-reported and confirmed via urine pregnancy test), lactating (self-reported), or post-menopausal (self-reported) females
  • Prisoners

Who the study is looking for

  • \- Body mass index 30 - 40 kg/m2

Age in the registry: 18 years to 45 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Florida State University
Coordinator of this site? Confirm its status
TallahasseeUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.